Effect of quercetin on the proliferation of the human ovarian cancer cell line SKOV-3 in vitro

Experimental and Therapeutic Medicine

Volumn 10, Issue 2, 2015, Pages 579-583

  Ren, Ming Xin ^a   Deng, Xiao Hui ^a   Ai, Fang ^b   Yuan, Guo Yan ^b   Song, Hai Yan ^a  

^a XINXIANG MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Ovarian cancer; Proliferation; Quercetin; Survivin

Indexed keywords

QUERCETIN; SURVIVIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; MTT ASSAY; OVARY CANCER; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 84931838411     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2536     Document Type: Article

References (16)

1. Gilbert L, Basso O, Sampalis J, et al; DOvE Study Group: Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project. Lancet Oncol 13: 285-291, 2012.
2. Jelovac D and Armstrong DK: Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin 61: 183-203, 2011.
3. Drake B: Intraperitoneal chemotherapy: a reemerging approach in the treatment of ovarian cancer. J Infus Nurs 32: 314-322, 2009.
4. Slusarz A, Shenouda NS, Sakla MS, et al: Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res 70: 3382-3390, 2010.
5. Comalada M, Camuesco D, Sierra S, et al: In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur J Immunol 35: 584-592, 2005.
6. Ma L, Feugang JM, Konarski P, et al: Growth inhibitory effects of quercetin on bladder cancer cell. Front Biosci 11: 2275-2285, 2006.
7. Beniston RG and Campo MS: Quercetin elevates p27(Kip1) and arrests both primary and HPV16 E6/E7 transformed human keratinocytes in G1. Oncogene 22: 5504-5514, 2003.
8. Yoshida M, Yamamoto M and Nikaido T: Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res 52: 6676-6681, 1992.
9. Paydar M, Wong YL, Moharam BA, et al: In vitro anti-oxidant and anti-cancer activity of methanolic extract from Sanchezia speciosa leaves. Pak J Biol Sci 16: 1212-1215, 2013.
10. Psahoulia FH, Drosopoulos KG, Doubravska L, et al: Quercetin enhances TRAIL-mediated apoptosis in colon cancer cells by inducing the accumulation of death receptors in lipid rafts. Mol Cancer Ther 6: 2591-2599, 2007.
11. Lai WW, Hsu SC, Chueh FS, et al: Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways. Anticancer Res 33: 1941-1950, 2013.
12. Bruning A: Inhibition of mTOR signaling by quercetin in cancer treatment and prevention. Anticancer Agents Med Chem 13: 1025-1031, 2013.
13. Nguyen TT, Tran E, Nguyen TH, et al: The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 25: 647-659, 2004.
14. Hamedeyazdan S, Fathiazad F, Sharifi S and Nazemiyeh H: Antiproliferative activity of Marrubium persicum extract in the MCF-7 human breast cancer cell line. Asian Pac J Cancer Prev 13: 5843-5848, 2012.
15. Borska S, Chmielewska M, Wysocka T, et al: In vitro effect of quercetin on human gastric carcinoma: targeting cancer cells death and MDR. Food Chem Toxicol 50: 3375-3383, 2012.
16. Yi L, Zongyuan Y, Cheng G, Lingyun Z, Guilian Y and Wei G: Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway. Cancer Sci 105: 520-527, 2014.